Company profile · Vilnius, Lithuania

Gensinta UAB

Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools · Synthetic biology tools R&D

Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.

Lead
Benas Macijauskas (verified ↗)
Address
Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania (source ↗)
Compliance
Not yet on record
Last reviewed
24 Apr 2026 (1mo ago)
Scale
Synthetic biology tools R&D
Capabilities
New-Generation DNA Synthesis · Molecular Biology and Photonics Integration · Synthetic Biology R&D
Founded
2019
Headcount
1-10
Site and address
Clinical profileSTATUS: VERIFIED APRIL 2026

Benas Macijauskas

Chief Executive Officer

Check official leadership source
Full addressVilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source

LithuaniaBIO members catalogue listing Gensinta UAB.

Open source
Operating profile

Synthetic biology tools R&D

Vilnius, Lithuania. Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools. Review completed on 24 Apr 2026.

2026 technical specializationSynthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools
Core capabilities
New-Generation DNA SynthesisMolecular Biology and Photonics IntegrationSynthetic Biology R&D
Governance

Lithuanian innovation authorities for startup support

LithuaniaBIO association member, Vilnius City Innovation Industrial Park tenancy, Public CEO disclosure

Editorial note

Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools

Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.

Editorial note

Gensinta is a Vilnius synthetic biology startup with a named CEO, Vilnius City Innovation Industrial Park tenancy, and active LithuaniaBIO association membership.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026Last reviewed: 24 April 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

New-Generation DNA Synthesis
Molecular Biology and Photonics Integration
Synthetic Biology R&D
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceNorthtown Vilnius announcement naming Benas Macijauskas as CEO of Gensinta.Source origin: northtownvilnius.ltOpen source
Supporting evidenceLithuaniaBIO association members catalogue listing Gensinta UAB.Source origin: lithuaniabio.comOpen source
Physical-site evidenceLithuaniaBIO members catalogue listing Gensinta UAB.Source origin: lithuaniabio.comOpen source
Infrastructure

Declared infrastructure

DNA synthesis platform
Photonics integration workflow
Innovation Industrial Park tenancy
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Gensinta UAB located?
Gensinta UAB operates from Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania, Vilnius, Lithuania.
Who runs Gensinta UAB?
Gensinta UAB is led by Benas Macijauskas, Chief Executive Officer. Verified 24 Apr 2026.
What does Gensinta UAB do?
Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology. Core capabilities: New-Generation DNA Synthesis, Molecular Biology and Photonics Integration, Synthetic Biology R&D.
Editorial context

Related technical briefs

Briefs that name Vilnius as a covered market or city.